发明名称 |
MICRORNAS FOR PREDICTION OF TREATMENT EFFICACY AND PROGNOSIS OF CANCER PATIENTS |
摘要 |
The present invention lies within the field of personalised medicine. More particular the invention relates to biomarkers useful for predicting treatment efficacy and prognosis in cancer patients. Thus the invention provides microRNAs (miRNAs) which are useful for predicting efficacy of anti-angiogenic treatment. In particular, miR-664 for the prediction of response to bevacizumab in colorectal cancer of sigmoid colon or rectum. |
申请公布号 |
EP2804959(A2) |
申请公布日期 |
2014.11.26 |
申请号 |
EP20130702886 |
申请日期 |
2013.01.16 |
申请人 |
HERLEV HOSPITAL |
发明人 |
BOISEN, MOGENS KARSBØL;JOHANSEN, JULIA SIDENIUS |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|